BackSilence Therapeutics Plc Overview

Silence Therapeutics Plc Total Liabilities

Track Silence Therapeutics Plc's total liabilities ($68M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$67.94M
↓ 4.41% YoYΔ $-3.14M vs prior year quarter

Peer trimmed avg / median

Loading

Silence Therapeutics Plc Total Liabilities History

Loading

Silence Therapeutics Plc vs. peers: Total Liabilities Comparison

Loading

Silence Therapeutics Plc Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Silence Therapeutics Plc (SLN) FAQ

As of the most recent data (June 2026), SLN shows a total liabilities of $68M. That compares with $71M in the prior-year period — down 4.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SLN's total liabilities is now $68M (was $71M) — a 4.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Silence Therapeutics Plc is outperforming or lagging.

Tracking SLN's total liabilities over time shows whether Silence Therapeutics Plc is scaling, shrinking, or reshaping that part of the business. The current reading is $68M That compares with $71M in the prior-year period — down 4.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Silence Therapeutics Plc's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $68M) with ownership activity and broader fundamentals.

Silence Therapeutics Plc's total liabilities is $68M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.